factually
Index/Topics/Ivermectin and Balstilimab Trial NCT05318469

Ivermectin and Balstilimab Trial NCT05318469

Trial of ivermectin and balstilimab combination for metastatic triple-negative breast cancer with reported tolerability and early clinical benefit signals

Fact-Checks

1 result
Jan 12, 2026

What published results exist from NCT05318469 (ivermectin + balstilimab) regarding safety and pharmacokinetics?

Published results for NCT05318469 are limited to conference abstracts and trial summaries that report tolerability and early activity signals: an ASCO/Journal of Clinical Oncology abstract states the ...